Literature DB >> 23634355

Treating patients with medically resistant epilepsy.

Gregory L Krauss1, Michael R Sperling.   

Abstract

Recent evidence suggests that medically resistant epilepsy can be identified if seizures persist despite adequate doses of 2 appropriate first-line antiepileptic drugs (AEDs). Patients with medically resistant epilepsy should have their seizures carefully characterized in order to confirm their diagnosis, select treatment, and assist in determining prognosis. Patients should be counseled about factors that aggravate epilepsy and the importance of adhering to treatments. Physicians should carefully inquire about side effects and alter therapy to eliminate or minimize these symptoms. Uncontrolled seizures cause injuries, disability, and increased mortality, so surgery should be considered as soon as seizures are proven to be medically resistant. Patients with incomplete response to AEDs and who are not surgical candidates may benefit from additional medication trials or from palliative nonmedical therapies, such as vagal nerve stimulation.

Entities:  

Year:  2011        PMID: 23634355      PMCID: PMC3613191          DOI: 10.1212/CPJ.0b013e31823d07d1

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  34 in total

1.  Historical criteria that distinguish syncope from seizures.

Authors:  Robert Sheldon; Sarah Rose; Debbie Ritchie; Stuart J Connolly; Mary-Lou Koshman; Mary Anne Lee; Michael Frenneaux; Michael Fisher; William Murphy
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

Review 2.  When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy.

Authors:  Andrew Nicolson; Anthony G Marson
Journal:  Pract Neurol       Date:  2010-08

Review 3.  Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?

Authors:  G Zaccara; A Messori; M Cincotta; G Burchini
Journal:  Acta Neurol Scand       Date:  2006-09       Impact factor: 3.209

4.  Personality Assessment Inventory among patients with psychogenic seizures and those with epilepsy.

Authors:  S Marc Testa; Ronald P Lesser; Gregory L Krauss; Jason Brandt
Journal:  Epilepsia       Date:  2011-07-08       Impact factor: 5.864

5.  Diagnosing refractory epilepsy: response to sequential treatment schedules.

Authors:  R Mohanraj; M J Brodie
Journal:  Eur J Neurol       Date:  2006-03       Impact factor: 6.089

6.  Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center.

Authors:  Maria A Montenegro; Hiba Arif; Edmund A Nahm; Stanley R Resor; Lawrence J Hirsch
Journal:  Clin Neuropharmacol       Date:  2008 Nov-Dec       Impact factor: 1.592

7.  Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood.

Authors:  Willem F M Arts; Oebele F Brouwer; A C Boudewijn Peters; Hans Stroink; Els A J Peeters; Paul I M Schmitz; Cees A van Donselaar; Ada T Geerts
Journal:  Brain       Date:  2004-06-16       Impact factor: 13.501

8.  The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study.

Authors:  A Jacoby; G A Baker; N Steen; P Potts; D W Chadwick
Journal:  Epilepsia       Date:  1996-02       Impact factor: 5.864

9.  Comparison and predictors of rash associated with 15 antiepileptic drugs.

Authors:  H Arif; R Buchsbaum; D Weintraub; S Koyfman; C Salas-Humara; C W Bazil; S R Resor; L J Hirsch
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

10.  The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

View more
  14 in total

Review 1.  Optogenetics: the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system.

Authors:  Bruno Camporeze; Bruno Alcântara Manica; Gabriel Alves Bonafé; Jivago Jordão Camargos Ferreira; Aurélio Lourenço Diniz; Carlos Tadeu Parisi de Oliveira; Luis Roberto Mathias Junior; Paulo Henrique Pires de Aguiar; Manoela Marques Ortega
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

2.  Neurovascular Drug Biotransformation Machinery in Focal Human Epilepsies: Brain CYP3A4 Correlates with Seizure Frequency and Antiepileptic Drug Therapy.

Authors:  Sherice Williams; Mohammed Hossain; Lisa Ferguson; Robyn M Busch; Nicola Marchi; Jorge Gonzalez-Martinez; Emilio Perucca; Imad M Najm; Chaitali Ghosh
Journal:  Mol Neurobiol       Date:  2019-06-26       Impact factor: 5.590

Review 3.  Pannexin 1 channels and ATP release in epilepsy: two sides of the same coin : The contribution of pannexin-1, connexins, and CALHM ATP-release channels to purinergic signaling.

Authors:  Elena Dossi; Nathalie Rouach
Journal:  Purinergic Signal       Date:  2021-09-08       Impact factor: 3.765

4.  Approach to the patient with transient alteration of consciousness.

Authors:  Thomas R Henry; Mustapha A Ezzeddine
Journal:  Neurol Clin Pract       Date:  2012-09

Review 5.  Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

Authors:  Gashirai K Mbizvo; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

6.  Phenytoin Augmentation of Levetiracetam Treatment: A Case of Forced Normalization With Emergence of Psychosis.

Authors:  Michael Esang; Vijaya Padma Kotapati; Saeed Ahmed
Journal:  Cureus       Date:  2018-04-05

7.  Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine-resistant amygdala kindling model.

Authors:  Cameron S Metcalf; Jennifer Huff; Kyle E Thomson; Kristina Johnson; Sharon F Edwards; Karen S Wilcox
Journal:  Epilepsia Open       Date:  2019-08-12

8.  Fish Oil Intake and Seizure Control in Children with Medically Resistant Epilepsy.

Authors:  Diala Mohamed Ali Reda; Nesrin Kamal Abd-El-Fatah; Tarek El-Sayed Ismail Omar; Olfat Abdel Hamid Darwish
Journal:  N Am J Med Sci       Date:  2015-07

9.  Static magnetic fields reduce epileptiform activity in anesthetized rat and monkey.

Authors:  Casto Rivadulla; Juan Aguilar; Marcos Coletti; Jordi Aguila; Sandra Prieto; Javier Cudeiro
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

10.  Stereotactic EEG-guided radiofrequency thermocoagulation versus anterior temporal lobectomy for mesial temporal lobe epilepsy with hippocampal sclerosis: study protocol for a randomised controlled trial.

Authors:  Yi-He Wang; Si-Chang Chen; Peng-Hu Wei; Kun Yang; Xiao-Tong Fan; Fei Meng; Jia-Lin Du; Lian-Kun Ren; Yong-Zhi Shan; Guo-Guang Zhao
Journal:  Trials       Date:  2021-06-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.